Cancer stem cells and the ontogeny of lung cancer

Craig D. Peacock, D. Neil Watkins

Research output: Contribution to journalArticle

Abstract

Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.

Original languageEnglish (US)
Pages (from-to)2883-2889
Number of pages7
JournalJournal of Clinical Oncology
Volume26
Issue number17
DOIs
StatePublished - 2008

Fingerprint

Neoplastic Stem Cells
Lung Neoplasms
Stem Cells
Neoplasms
Cause of Death
Recurrence
Lung
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Cancer stem cells and the ontogeny of lung cancer. / Peacock, Craig D.; Watkins, D. Neil.

In: Journal of Clinical Oncology, Vol. 26, No. 17, 2008, p. 2883-2889.

Research output: Contribution to journalArticle

Peacock, Craig D. ; Watkins, D. Neil. / Cancer stem cells and the ontogeny of lung cancer. In: Journal of Clinical Oncology. 2008 ; Vol. 26, No. 17. pp. 2883-2889.
@article{ad8cbe0c443b43239fde3309a3a91b5d,
title = "Cancer stem cells and the ontogeny of lung cancer",
abstract = "Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.",
author = "Peacock, {Craig D.} and Watkins, {D. Neil}",
year = "2008",
doi = "10.1200/JCO.2007.15.2702",
language = "English (US)",
volume = "26",
pages = "2883--2889",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "17",

}

TY - JOUR

T1 - Cancer stem cells and the ontogeny of lung cancer

AU - Peacock, Craig D.

AU - Watkins, D. Neil

PY - 2008

Y1 - 2008

N2 - Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.

AB - Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=45549097925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549097925&partnerID=8YFLogxK

U2 - 10.1200/JCO.2007.15.2702

DO - 10.1200/JCO.2007.15.2702

M3 - Article

VL - 26

SP - 2883

EP - 2889

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 17

ER -